Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients

Diabetic Medicine

Volumn 16, Issue 7, 1999, Pages 579-585

  Mannucci, E ^a   Bardini, G ^a   Ognibene, A ^b   Rotella, Carlo M ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Sezione Malat del Metabolismo e D   (Italy)

Author keywords

Diabetes mellitus; Fasting glycaemia; Impaired fasting glycaemia; Impaired glucose tolerance; Obesity; Oral glucose tolerance test; Screening

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROGNOSIS; SCREENING TEST; WORLD HEALTH ORGANIZATION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; SOCIETIES, MEDICAL; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 0032725522     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00116.x     Document Type: Article

References (39)

1. 1 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
2. 2 Alberti KGMM, Zimmer PZ for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 1998; 15: 539-553.
3. 3 Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the US population aged 20-74 yr. Diabetes 1987; 36: 523-534.
4. 4 McCance DR, Hanson RL, Charles MA, Jacobsson, LTH, Pettitt DJ, Bennett PH et al. Comparison of rests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. Br Med J 1994; 308: 1323-1328.
5. 1c levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care 1997; 20: 785-791.
6. 6 Gault A, O'Dea K, Rowley KG, McLeay T, Traianedes K. Abnormal glucose tolerance and other coronary heart disease risk factors in an isolated aboriginal community in central Australia. Diabetes Care 1996; 19; 1269-1273.
7. 7 Tanaka Y, Atsumi Y, Asahina T, Hosokawa K, Matsuoka K, Kinoshita J et al. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects. Diabetes Care 1998; 21: 1133-1137.
8. 8 Mannucci E, Bardini G, Ognibene A, Rotella CM. Screening for diabetes in obese patients using the new diagnostic criteria (Letter). Diabetes Care 1998; 21: 468-469.
9. 9 Alberti KGMM, Zimmet PZ. New diagnostic criteria and classification of diabetes - again? Diabet Med 1998; 15; 535-536.
10. 10 American Diabetes Association. Clinical Practice Recommendations. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998; 21: S36-S39.
11. 11 World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Technical Report Series 727. Geneva: WHO 1985.
12. 12 Di Cianni G, Benzi L, Giannarelli R, Orsini P, Villani G, Ciccarone AM et al. A prevalence study of known diabetes mellitus inTuscany assessed from pharmaceutical prescriptions and other independent sources. Acta Diabetol 1994; 31: 87-90.
13. 11 Pagano G, Bargero G, Vuolo A, Bruno G. Prevalence and clinical features of known type 2 diabetes in the elderly: a population-based study. Diabet Med 1994; 11: 475-479.
14. 14 Muggeo M, Verlato G, Bonora E, Bressan F, Girotto S, Corbellini M et al. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 1995; 38: 318-325.
15. 15 Garancini MP, Sergi A, Lazzari P, Gallus G. Epidemiology of known diabetes in Lombardy, north Italy. Clinical characteristics and methodological aspects. Acta Diabetol 1995; 32: 268-272.
16. 16 Garancini MP, Calori G, Ruotolo G, Manara E, Izzo A, Ebbli E et al. Prevalence of IDDM and impaired glucose tolerance in Italy: an OGTT-based population study. Diabetologia 1995; 38: 306-313.
17. 17 Jimenez JT, Palacios M, Canete F, Barrrocanal LA, Medina U, Figueredo R et al. Prevalence of diabetes mellitus and associated risk factors in an adult urban population in Paraguay. Diabet Med 1998; 15: 334-338.
18. 18 Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey. 1988-94. Diabetes Care 1998; 21: 518-524.
19. 19 DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. Br Med J 1998; 317: 371-375.
20. 20 Hanley AJG, Harris SB, Zinman B. Application of the revised American Diabetes Association criteria for the diagnosis of diabetes in a Canadian native population. (Letter). Diabetes Care 1998; 21; 870-871.
21. 21 Alberti KG, The clinical implications of impaired glucose tolerance. Diabet Med 1996; 13: 927-937.
22. 22 Heine RJ, Nijpels G, Mooy JM. New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors. Diabet Med 1996; 13: S12-S14.
23. 23 Warram JH, Sigal RJ, Martin BC, Krolewski AS, Soeldner JS. Natural histiry of impaired glucose tolerance: follow-up at Joslin Clinic. Diabet Med 1996, 13: S40-S45.
24. 24 Qiao Q, Keinanen-Kiukaannieni S, Rajala U, Uusimaki A, Kivela SL. Risk for diabetes and persistent impaired glucose tolerance among middle-aged Finns. Diabetes Res Clin Pract 1996; 33: 191-198.
25. 25 Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997; 46: 701-710.
26. 26 Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E. Risk factors for NIDDM in white population. Paris Prospective Study. Diabetes 1991; 40: 769-799.
27. 27 Chou P, Li CL, Wu GS, Tsai ST. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. Diabetes Care 1998; 21: 1183-1187.
28. 28 Bourn DM. The potential for lifestyle change to influence the progression of impaired glucose tolerance to non-insulin-dependent diabetes mellitus. Diabet Med 1996; 13: 938-945.
29. 29 Unwin N, Alberti KGMM, Bhopal R, Harland J, Watson W, White M. Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. Diabet Med 1998; 15: 554-557.
30. 1c, and fasting plasma glucose as first-line diagnostic tests for diabetes mellitus. Diabet Med 1998; 15: 558-563.
31. 31 Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states: relationship to atherogenesis. Diabetes Care 1991; 14: 839-847.
32. 32 Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV. Multivariate analysis of the insulin resistance syndrome in women. ArteriosclerThromb 1994; 12: 1940-45.
33. 33 Meigs JB, D'Agostino RBSr, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997; 46: 1594-1600.
34. 34 Edwards KL, Burchfiel CM, Sharp DS, Curb JD, Rodriquez BL, Fujimoto WY et al. Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol 1998; 147:441-447.
35. 35 Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and cenral and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism 1996; 45: 699-706.
36. 36 Vanhala MJ, Kumpusalo EA, Pitkajarvi TK, Notkola IL, Takala JK. Hyperinsulinemia and clustering of cardiovascular risk factors in middle aged hypertensive Finnish men and women. J Hypertens 1997; 15: 475-481.
37. 37 Riccardi G, Vaccaro O, Rivellese A, Pignalosa S, Tutino L, Mancini M. Reproducibility of the new diagnostic criteria for impaired glucose tolerance. Diabetes Care 1988; 11: 253-257.
38. 38 Yudkin JS, Alberti KGMM, McLarty DG, Swai ABM. Impaired glucose tolerance. Is it a risk factor for diabetes or a diagnostic ragbag? Br Med J 1990; 301: 397-402.
39. 39 Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 1998; 35: 62-67.